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Abstract
Functional deficits are a hallmark of schizophrenia spectrum disorders, but much debate still exists over why
and how they originate. One model suggests that disturbances in social functioning are a result of
metacognitive deficits or a failure to integrate information to form more complex ideas of themselves and
others. It is unclear if this social dysfunction is present across different symptom presentations. We examined
the relationship of metacognition, symptoms, and social functioning among a sample of adults with
schizophrenia spectrum disorders (N ¼ 334). A latent class analysis produced a four-class model. Groups
were classified as follows: diffuse symptoms/moderately impaired social functioning (Class 1), positive and
hostility symptoms/mildly impaired social functioning (Class 2), minimal symptoms/good social functioning
(Class 3), and negative and cognitive symptoms/severely impaired social functioning (Class 4). Class 3
demonstrated better overall metacognitive capacity than both Classes 1 and 4 but did not differ significantly
from Class 2. Classes 2 and 3 both demonstrated better interpersonal functioning than Classes 1 and 4.
Together, these findings provide support for models of poor functioning that stem from fragmentation of
an individual’s experience, leading to diminished abilities to form meaningful connections with others.
Additional interpretations, limitations, and research implications are discussed.
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Introduction
Bleuler (1952 [1911]) proposed that schizophrenia is
a heterogenous set of disorders all characterized by
the splitting or fragmentation of one’s experience,
resulting in an interrupted life course. Specifically,
he suggested that disturbances occur in association,
affect, and ambivalence which then result in with-
drawal from the world, which he characterized as
autism. As a consequence of these disturbances, the
meanings people make of their experiences, and thus
support goal-directed behaviors, disappear. As such,
the framework that enables an enduring sense of con-
nection to the social world also disappears (Maatz,
Hoff, & Angst, 2015). Bleuler’s view stood in contrast
to those of Kraepelin (2002 [1919]), who posited that
organic, metabolic processes caused deficits in voli-
tion and affect, which in turn caused the loss of adap-
tive functioning (Noll, 2011).
Researchers have continued to explore the notion
that social dysfunction in schizophrenia is a result of
fragmentation. One model has proposed that persons
with this condition experience disturbance in social
functioning as a result of metacognitive deficits or a
failure to integrate information into a complex sense
of oneself, others, and their place in a larger commu-
nity (Lysaker, Hamm, Hasson-Ohayon, Pattison, &
Leonhardt, 2018). This perspective is based on the
integrated model (Lysaker & Dimaggio, 2014; Lysa-
ker et al., this issue), wherein metacognition refers to
a spectrum of processes ranging from awareness of
discrete thoughts, feelings, and bodily experiences to
the synthesis of those experiences into a larger sense
of oneself and others as unique beings. Disturbances
in these processes could thus potentially explain why
individuals with schizophrenia often demonstrate a
fragmented sense of themselves and others (Lysaker
et al., 2018). As such, it is suggested that metacogni-
tive deficits leave individuals without a coherent
understanding of either their own or others’ experi-
ences, needs, and wishes, thus leading to social dys-
function (Bonfils, Luther, Buck, George, & Lysaker,
2016; Lysaker & Klion, 2017).
Several studies have put forth evidence that frag-
mentation resulting from metacognitive deficits may
contribute to social dysfunction. As reviewed else-
where (Lysaker et al., this issue), evidence suggesting
that metacognitive deficits can be commonly
observed in schizophrenia and are a barrier to recov-
ery has steadily accumulated. Cross-sectional
research has also found that the lower levels of meta-
cognitive abilities predict concurrent deficits in social
functioning (Bro¨cker et al., 2017; Lysaker et al., 2005,
2010a, 2011a; Masse´ & Lecomte, 2015), independent
of other factors thought to contribute to these deficits,
including dysfunctional beliefs (James et al., 2016)
and social cognition (Lysaker et al., 2013). Other
studies have found metacognition predicted social
functioning prospectively over a 5-month interval
(Lysaker et al., 2011b) and that changes in metacog-
nitive capacity were associated with improvements in
social skills (Inchausti et al., 2017a). Support for a
link between metacognition and social functioning
can also be found in research suggesting that meta-
cognitive deficits predict multiple psychological con-
structs and biological processes believed to be
cornerstones of social functioning, including intrinsic
motivation (Luther et al., 2016, 2017), complexity of
social schema (Lysaker et al., 2010b), anhedonia
(Buck et al., 2014), aggression (de Jong et al.,
2018), sense of social connection (Kukla, Lysaker,
& Salyers, 2013), empathy (Bonfils, Lysaker, Minor,
& Salyers, 2018; WeiMing, Yi, Lysaker, & Kai,
2015), and levels of oxytocin (Aydin, Lysaker,
Balıkc¸ı, U¨nal-Aydın, & Esen-Danacı, 2018).
Importantly, one limitation of the existing research
exploring the relationship between metacognition and
social function in schizophrenia is that, due to small
sample sizes, studies have not explored the way in
which metacognitive deficits may be differentially
related to social functioning across varying symptom
presentations. An example of clinical features that
may differentially relate to social functioning is pos-
itive and negative symptoms. Positive symptoms have
been traditionally thought to affect social functioning
when they erode trust in others or lead to anomalous
experiences that others cannot understand, contribut-
ing to social isolation (Hooker et al., 2011; Yanos,
Roe, Markus, & Lysaker, 2008). In contrast, negative
symptoms interfere with the detection and expression
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of emotional experiences. These skills are the basis
for intersubjectivity and when they are derailed can
impact individuals’ ability to connect with others.
To address the question of whether metacognition
is related to social functioning across persons with
different symptom presentations, the present study
examined the relationships of metacognition, symp-
toms, and social functioning among a relatively large
sample of adults with schizophrenia spectrum disor-
ders. Specifically, we had two aims. First, we sought
to identify different configurations of social function-
ing and symptoms using latent class analysis (LCA).
We chose this statistical approach to classification
rather than methods that employ a priori predictions
to minimize the effects of any preexisting biases
regarding which underlying symptom and social func-
tioning profiles exist naturally. The second aim was to
explore whether those with impaired social function-
ing experienced greater metacognitive deficits regard-
less of symptom profile. We chose not to include
metacognition in the LCA because we wished to
identify individuals with varying symptom profiles
(psychiatric and functioning) and then see how meta-
cognition varied across them. We did not wish to base
the classification of the groups on metacognition, as
this would have obfuscated the distinct symptom con-
stellations that create these varying groups. We pre-
dicted we would identify a group with good, or
unimpaired, social functioning and relatively less
severe symptoms and groups with impaired social
functioning and varying symptoms presentations: pri-
marily positive symptoms, primarily negative symp-
toms, and a group with diffuse positive and negative
symptoms. We predicted all impaired social function-
ing groups would show greater deficits in metacogni-
tion than the good social functioning group,
regardless of the symptom presentation.
Method
Participants
Participants were 334 adults receiving outpatient
mental health treatment with a diagnosis of schizo-
phrenia (230) or schizoaffective disorder (104) based
on the Structured Clinical Interview for DSM-IV
(SCID-IV; First, Spitzer, Gibbon, & Williams,
2002). Individuals were participants in studies of the
effects of psychosocial rehabilitation; recruitment and
study procedures occurred at a Veterans’ Affairs
Medical Center in Indiana as well as community men-
tal health centers in Indiana and New Jersey.
Inclusion criteria required that individuals were in a
non-acute phase of illness, defined by no hospitaliza-
tions or changes in housing or medication within 30
days of study enrollment. The mean age of the parti-
cipants was 43.54 years (range: 18–71; SD ¼ 12.58).
The sample was 77.2% male (n ¼ 257) and 22.8%
female (n ¼ 76), and the mean years of education
were 11.53 years (range: 2–24; SD ¼ 3.23). Addi-
tional descriptive statistics for the full sample can
be found in Table 1.
Instruments
Indiana Psychiatric Illness Interview (IPII; Lysaker,
Clements, Plascak-Hallberg, Knipscheer, & Wright,
2002): The IPII is a semi-structured interview
designed to encourage individuals to provide a sample
of how they think about challenges in their life, par-
ticularly those related to psychiatric illness. The inter-
view typically lasts 30 to 60 min, during which the
interviewer asks participants to talk about: (1) the
story of their life thus far; (2) whether they think they
have a mental illness and, if so, how that has affected
and not affected their thoughts, emotions, and beha-
viors; (3) the influence the condition has had on their
lives as well as their influence on their condition;
(4) the influence of their condition on others and oth-
er’s influence over their condition; and (5) their
thoughts about their future. The IPII elicits a nuanced
account of psychiatric challenges that extend beyond
Table 1. Demographic and clinical characteristics of full
sample (N ¼ 334).
M SD
Age 43.54 12.58
Gender (n, % male) 257 76.90%
Education 11.53 3.23
Self 4.29 1.39
Other 2.87 0.94
Decentration 0.58 0.71
Mastery 3.43 1.74
MAS total 11.17 3.88
QLS interpersonal total 20.14 9.11
QLS intrapsychic total 22.16 6.37
PANSS negative 18.75 5.72
PANSS positive 15.9 4.8
PANSS cognitive 17.43 4.55
PANSS hostility 7.28 2.79
PANSS emotional discomfort 12.46 4.26
Note. MAS ¼ Metacognition Assessment Scale; QLS ¼ Quality of
Life Scale; PANSS ¼ Positive and Negative Syndrome Scale.
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the bounds of discussing psychiatric labels, and as
such can serve as the basis for the assessments of
metacognitive capacity.
Metacognition Assessment Scale–Abbreviated
(MAS-A; Lysaker et al., 2005): The MAS-A was used
to rate metacognition on the basis of a typed transcript
of the IPII. The MAS-A is an adaptation of the MAS
which was originally designed to study metacognition
within psychotherapy transcripts (Semerari et al.,
2003). The MAS-A transformed the original items
of the MAS into four ordinal scales. These scales
represent the following domains: self-reflectivity (S)
or the extent to which individuals have a more frag-
mented or more integrated sense of self; awareness of
others (O) or the degree to which a person has an
integrated or fragmented sense of other people;
decentration (D), which assesses the degree to which
a person has an integrated or fragmented sense of their
position within the larger community; and mastery
(M), which assesses the degree to which a person can
use metacognitive knowledge to respond to psycho-
social challenges. The MAS-A frames metacognition
as a series of increasingly complex and hierarchical
processes, such that once it is determined that an indi-
vidual did not attain a particular level, it is assumed
that no further levels can be meaningfully achieved.
Thus, higher scores represent higher levels of meta-
cognitive abilities. Good inter-rater reliability and
validity have been presented elsewhere with intraclass
correlations ranging from .80 to .92 for the MAS-A
subscales (Lysaker et al., 2005, 2011b, 2013; Nicolo`
et al., 2012).
Positive and Negative Syndrome Scale (PANSS;
Kay, Fiszbien, & Opler, 1987): The PANSS is a 30-
item rating scale used for measuring symptom sever-
ity of patients with schizophrenia and other mental
disorders. In this study, we used the Bell, Lysaker,
Beam-Goulet, Milstein, and Lindenmayer’s (1994)
factor analytically derived model which produces the
following five component scores: positive (scores
ranging from 6 to 42), negative (ranging from 8 to
56), cognitive (ranging from 7 to 49), emotional dis-
comfort (ranging from 4 to 28), and hostility (ranging
from 4 to 28). Good inter-rater reliability was found in
prior studies (Kay et al., 1987; Lysaker et al., 2013).
Quality of Life Scale (QLS; Heinrichs, Hanlon, &
Carpenter, 1984): The QLS is a 21-item scale com-
pleted by a trained rater following a semi-structured
interview where the interviewer asks the participant
questions about his or her daily life and functioning. It
has been widely used as a measure of psychosocial
functioning due to its ability to detect strengths and
weaknesses in the areas of interpersonal, community,
and work functioning (Brekke, Raine, Ansel, Lencz,
& Bird, 1997; Lysaker, Bell, Bryson, & Kaplan,
1998). For the purposes of this study, we focused on
the interpersonal and intrapsychic subscales; the inter-
personal subscale measures the frequency and nature
of recent social interactions, and the intrapsychic sub-
scale measures qualitative and foundational aspects of
social interactions. Previous studies have found good
intraclass correlations (Lysaker et al., 1998). Higher
scores are suggestive of better levels of functioning.
Procedure
Procedures were approved by the local Institutional
Review Boards. After written informed consent was
obtained from participants, clinical psychologists
confirmed diagnoses by meeting with participants and
using the SCID-IV. Trained master’s-level research
assistants subsequently administered the instruments
as part of a baseline assessment. All measures were
collected prior to randomization into a trial of psycho-
social rehabilitation. Raters of the MAS-A were blind
to PANSS and QLS scores, and PANSS and QLS
raters were blind to IPII content or MAS-A scores.
Analytical strategy
Statistical analyses were conducted using SPSS ver-
sion 24 and Mplus version 7 (Muthe´n & Muthe´n,
2012). First, we conducted an LCA in order to iden-
tify the potential presence of homogenous groups of
individuals based on symptomatology and QLS
intrapsychic foundations. Previous research suggests
that the QLS intrapsychic scale is more closely tied to
metacognition than is the interpersonal relations scale
(Lysaker et al., 2013). In the second phase, we con-
ducted a series of analyses of variance (ANOVAs) to
compare demographics and MAS-A scores between
groups and utilized the Bonferroni correction for mul-
tiple comparisons. In the third phase, we conducted a
set of analyses of covariance to control for gender and
education level. Finally, we conducted an exploratory
ANOVA comparing the four groups on the QLS inter-
personal subscale in order to further characterize the
sample and confirm that individuals differed on social
functioning using a separate index of social skill.
LCA can be employed to statistically identify
latent homogenous groups (classes) of individuals
from categorical and continuous multivariate data.
The approach is based on probabilistic models of
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subgroup membership rather than arbitrary or theore-
tical approaches utilized in other clustering methods
(Muthe´n & Muthe´n, 2012). In the present study,
LCA was used to identify latent classes of individu-
als with schizophrenia spectrum disorders based on
PANSS symptom subscales and the QLS intrap-
sychic subscale. Differences among classes on
demographic variables and metacognitive ability
were calculated using ANOVA and w2 tests (signifi-
cance level of p < .05).
The number of classes were not hypothesized a
priori but were determined from an examination of
model fit statistics, including entropy values,
Akaike’s information criteria (AIC; Akaike, 1987),
Bayesian information criteria (BIC; Schwarz, 1978),
and sample size-adjusted BIC (ssaBIC; Sclove, 1987)
(lower AIC, BIC, ssaBIC, and higher entropy values
indicating better fit). Bootstrapped likelihood ratio
tests (BLRT; McLachlan, 1987; Nylund, Asparouhov,
& Muthe´n, 2007) and Lo–Mendell–Rubin (LMR; Lo,
Mendell, & Rubin, 2001) tests, where n and n  1
number of classes are compared, were also conducted.
Results
Five LCA models were estimated specifying between
1 and 5 latent classes. The AIC and ssaBIC values
decreased with each successive class addition and
thus did not readily discriminate a model of best fit.
BIC values decreased for k ¼ 2–4 classes, but
increased for the k ¼ 5 model, suggesting the five-
class model is a poorer fit to the data. Entropy values
were adequate and increased in value for most models
(k ¼ 3–5), but decreased for k ¼ 5 class, again sug-
gesting the five-class model was a poorer fit. BLRTs
remained significant (p < .0001) with each successive
class addition to the model, thus not clearly discrimi-
nating a model of best fit. LMR likelihood ratio tests
were significant for k ¼ 2–4 classes, suggesting that
each successive addition of a class was a significant
improvement to the fit of the model; the LMR test for
k ¼ 5 was nonsignificant. Taken together with rela-
tionship to the extant literature and model interpret-
ability, it was determined the four-class model was
the best fit to the data.
Correlations between the PANSS subscale, QLS,
and MAS-A scores for the entire sample are found
in Table 2. Descriptive statistics for each of the
classes, including demographics, PANSS subscale,
QLS scores, and MAS-A scores, are found in Table 3.
Groups were classified as follows: diffuse symptoms/
moderately impaired social function (Class 1), posi-
tive and hostility symptoms/mildly impaired social
function (Class 2), minimal symptoms/good social
functioning (Class 3), and negative and cognitive
symptoms/severely impaired social functioning
(Class 4). Groups did not differ by age. Class 4 had
lower levels of education than other groups and Class
2 had a higher proportion of women.
ANOVAs and post hoc analyses using the Bonfer-
roni correction for multiple comparisons were per-
formed to compare classes on MAS-A scores. Class
3 had better overall metacognitive functioning than
both Classes 1 and 4. When comparisons were
repeated at the subscale level, these differences
appeared to be accounted for by the self-reflectivity
and mastery subscales. Class 3 did not differ in terms
of overall metacognitive capacity than Class 2. Given
the significant gender and education differences
between classes, we repeated these analyses
Table 2. Correlations among MAS-A, PANSS, and QLS subscales for full sample (N ¼ 334).
MAS-A
total
PANSS
negative
PANSS
positive
PANSS
cognitive
PANSS
hostility
PANSS
emotional
discomfort
QLS
interpersonal
total
QLS
intrapsychic
total
MAS-A total 1 0.28** 0.03 0.36** 0.06 0.22** 0.17** 0.27**
PANSS negative 1 0.14** 0.43** 0.01 0.06 0.44** 0.62**
PANSS positive 1 0.26** 0.38** 0.41** 0.21** 0.19**
PANSS cognitive 1 0.28** 0.02 0.24** 0.38**
PANSS hostility 1 0.33** 0.004 0.03
PANSS emotional discomfort 1 0.25** 0.06
QLS interpersonal total 1 0.061**
QLS intrapsychic total 1
MAS-A¼Metacognition Assessment Scale–Abbreviated; PANSS ¼ Positive and Negative Syndrome Scale; QLS¼Quality of Life Scale.
**p  .01.
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controlling for both variables. All group differences
on the MAS-A scores remained significant at the p <
.01 level.
Finally, to further characterize the sample,
classes were compared on the QLS interpersonal
subscale using ANOVA and post hoc analyses
using the Bonferroni correction for multiple com-
parisons. This analysis revealed that Classes 2 and
3 both demonstrated better interpersonal function-
ing than Classes 1 and 4.
Discussion
In this study, we empirically derived four classes of
individuals with schizophrenia spectrum disorders on
the basis of their social functioning and symptomatol-
ogy, and we sought to determine whether deficits in
metacognitive function were found in groups with
poorer social functioning. As predicted, we found four
groups: one with generally good social functioning
and three groups with differing levels of impaired
social functioning. As anticipated, the three groups
had distinct symptom presentations: one with predo-
minantly negative symptoms, one with predominantly
positive symptoms, and one with diffuse levels of
both positive and negative symptoms. Surprisingly,
the group with negative symptoms also had pro-
nounced cognitive symptoms, and the group with pos-
itive symptoms had concurrently higher levels of
hostility symptoms.
When we compared metacognitive capacity across
groups, our predictions were only partially confirmed:
the groups with poorest social functioning, those with
predominately negative/cognitive symptoms and
those with diffuse symptoms, had lower levels of
overall metacognition and greater impairment in
domains of self-reflectivity and mastery than the
group with good social functioning. Therefore, these
findings are consistent with models of poor function-
ing dating back to Bleuler that suggested fragmenta-
tion of an individual’s experience may result in some
form of social dysfunction.
While the cross-sectional nature of this study pre-
cludes drawing any causal conclusions, results may
suggest several hypotheses for future research. For
one, it is possible that relative inabilities to form a
complex and integrated sense of self and use that
information to respond to challenges results in the
presence of fewer resources for social relationships.
For example, it may be that the basic building blocks
for intimacy are compromised when persons cannot
synthesize discrete information into more complex
ideas that could guide behavior. Examination of mean
MAS-A scores suggests that the ability to understand
one’s own mental and emotional states as changing
and subjective is associated with greater levels of
social functioning, while the tendency to address psy-
chosocial challenges simply by gross avoidance
(rather than changing one’s behaviors or thoughts)
is associated with poorer social functioning. Of note,
alternative hypotheses cannot be ruled out, including
that with poorer social function, metacognitive capac-
ity is degraded, or that the link between these vari-
ables is the result of the presence of other
phenomenon such as attachment style (Gumley
et al., 2014) or trauma history (Pec, Bob, & Lysaker,
2015). Future research should explore these possible
relationships.
There were unexpected findings. The group with
predominantly positive and hostility symptoms con-
tained a higher proportion of women, and their meta-
cognitive capacity did not differ from the group with
good social function, though their metacognitive
capacity was superior to the group with prominent
negative symptoms. One possibility may be that pos-
itive symptoms (and perhaps hostility) may represent
a path to social dysfunction that is qualitatively dif-
ferent than others linked with negative or diffuse
symptoms and in which metacognitive deficits do not
play a major contributory role. A potential speculation
is that higher levels of arousal and positive symptoms
may be related to traumatic experiences, which may
uniquely impact social functioning (Bell, Robinson,
Katona, Fett, & Shergill, in press). Additionally,
affective symptoms are more commonly present in
women with schizophrenia (Goldstein & Link,
1988). Women also generally demonstrate better
social functioning than men in schizophrenia (Usall
et al., 2002) and the course of illness is often more
favorable in women as well (DeLisi, 2011). Men gen-
erally have poorer premorbid social adjustment and as
such, greater social disability (e.g., Addington, van
Mastrigt, & Addington, 2003). As with all unexpected
findings, future research is needed before any weight
is afforded to their interpretation.
There are limitations to the current study. Individ-
uals in the study were currently enrolled in outpatient
mental health treatment. As such, it is unclear whether
individuals in the community not seeking or refusing
treatment would demonstrate similar patterns of
functioning. We also only included persons with schi-
zophrenia spectrum disorders. It is consequently
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unknown if the relationships found here are specific to
schizophrenia or whether they may also apply to other
disorders where metacognitive deficits have been
observed to be linked to social functioning, including
Posttraumatic Stress Disorder (Davis et al., 2016;
Leonhardt, Lysaker, Vohs, James, & Davis, 2018),
affective disorders (Ladegaard, Lysaker, Larsen, &
Videbach, 2014; Lysaker, Hamm, et al., 2018), sub-
stance abuse (Inchausti, Ortun˜o-Sierra, Garcı´a-
Poveda, & Ballesteros-Prados, 2017b), and borderline
personality disorder (Lysaker et al., 2017). Assess-
ment of social functioning was completed by a trained
rater, and metacognition was assessed using a single
paradigm. As such, future research with different and
broader methodology is needed (e.g., self-report,
observation). Additionally, there may be conceptual
overlap between PANSS items (e.g., passive social
withdrawal) and our measures of social functioning
(e.g., QLS interpersonal functioning) that may have
impacted the pattern of results. Research is also
needed that examines other factors that may influ-
ence social functioning, including social cognition,
trauma, stigma, and neurocognition, particularly in
longitudinal designs. Finally, we did not assess med-
ication dosage or adherence so it is unknown to what
extent pharmacological treatment may have influ-
enced results.
With replication, results may have clinical impli-
cations. Interventions that target metacognition may
lead to the recovery of building blocks for healthy and
sustained social functioning (Lysaker, Gagen, Moritz,
& Schweitzer, 2018). Indeed, recovery from serious
mental illness has been conceptualized as a social
process (Scho¨n, Denjoy, & Topor, 2009; Tew et al.,
2012). If the framework that underlies an individual’s
ability to connect with others is disrupted, this can in
turn jeopardize attainment of recovery. As such, it is
critical that emphasis be placed on these constructs in
order to more fully support an individual’s recovery.
Potential candidates for this type of intervention
include metacognitive training (Moritz et al., 2014),
which promotes reflection upon reasoning processes
within the flow of life, and metacognitive reflection
and insight therapy (Lysaker & Klion, 2017), which
assists persons in forming and using more complex
understandings of themselves and others. These find-
ings, coupled with an analysis of a broad group of
case reports (Hamm & Lysaker, 2018; Hillis, Bidlack,
& Macobin, 2018; James, Leonhardt, & Buck, 2018;
Leonhardt, Ratliff, & Vohs, 2018), suggest that it may
be useful to include treatments such as these in larger
batteries which flexibly respond to the recovery needs
of patients.
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